博瑞医药股价涨5.18%，长城基金旗下1只基金重仓，持有2.83万股浮盈赚取13.01万元

Group 1 - On September 5, Borui Pharmaceutical experienced a 5.18% increase in stock price, reaching 93.19 CNY per share, with a trading volume of 675 million CNY and a turnover rate of 1.78%, resulting in a total market capitalization of 39.398 billion CNY [1] - Borui Pharmaceutical, established on October 26, 2001, and listed on November 8, 2019, is located in Suzhou Industrial Park, Jiangsu Province, and specializes in the research and production of high-end generic drugs and original new drugs [1] Group 2 - According to data from the top ten holdings of funds, one fund under Great Wall Fund has a significant position in Borui Pharmaceutical. The Great Wall SSE STAR 100 Index Enhanced A (023446) held 28,300 shares in the second quarter, accounting for 1.85% of the fund's net value, making it the ninth largest holding. The estimated floating profit today is approximately 130,100 CNY [2] - The Great Wall SSE STAR 100 Index Enhanced A (023446) was established on April 29, 2025, with a latest scale of 9.3575 million CNY and has achieved a return of 22.67% since inception [2]